Aller au contenu principal
2022 book-chapter

Pathophysiology of Primary and Secondary Movement Disorders

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

Abstract Primary and secondary movement disorders can present different etiologies and physiopathology. However, the malfunctioning of the corticobasal ganglia loops is implicated in most movement disorders. Hypokinetic signs such as bradykinesia, rigidity, gait disturbance, micrographia, precision grip impairment, and speech problems are mostly explained by overactivation of the so-called direct pathway and hypofunctioning of the indirect pathway of the basal ganglia. Such a hypokinetic state is in many cases the result of degeneration of midbrain dopamine neurons (e.g., Parkinson’s disease) or the side effect of antipsychotic drugs. The low motivational state observed in many patients with depression can also be the result of reduced levels of dopamine in the mesolimbic pathway. On the other hand, many hyperkinetic movement disorders result from hyperactivation of the direct pathway and inhibition of the direct pathway. Overstimulation of dopamine receptors in the striatum and prefrontal cortex is the most common cause of hyperkinetic syndromes, such as the levodopa-induced dyskinesia of Parkinson’s disease, and akathisia of schizophrenia, and restless legs syndrome. In Huntington’s disease, chorea is caused mostly by the loss of indirect pathway neurons. Other movement disorders are caused by cerebellum and frontal cortex dysfunctions. This chapter aims to provide insights into the normal and pathologic basal ganglia activity and its implications for movement disorders.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Pathophysiology of Primary and Secondary Movement Disorders
Date Crossref
01/11/2022
Éditeur
Oxford University PressNew York
Type
book-chapter

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Neurological disorders and treatmentsGenetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.